According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion independence compared with 15.0% of patients treated with placebo. Respondents ...
The next milepost for sweeping changes in the Minimum Data Set should come next week, when Chapters 2 and 4 and an appendix of the Resident Assessment Instrument (RAI) manual are published. The ...
RBC immunization is linked to reduced survival in transfusion dependent patients with myelodysplastic syndromes, independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results